Literature DB >> 7750939

"Quilty" revisited: a 10-year perspective.

A Joshi1, M A Masek, B W Brown, L M Weiss, M E Billingham.   

Abstract

The goals of this study were to better define Quilty lesions, facilitating differentiation from other endocardial infiltrates; to correlate Quilty lesions with clinical parameters; and to assess whether classification into Quilty A (noninvasive lesions) and Quilty B (invasive lesions) had clinical utility. Two hundred seventeen adults who received transplants between 1981 and 1987 and 22 children who received transplants between 1981 and 1989 were studied. Allograft survival for over 1 year was the selection criterion. Clinical, angiographic, and biopsy data were reviewed up to 1992, obtaining a minimum follow up of 5 years for adults and 3 years for children. All 7,439 endomyocardial biopsy cases were allotted an International Society for Heart and Lung Transplantation (ISHLT) grade for rejection, and Quilty was classified as Quilty A or B. Quilty was correlated with transplant recipient age and gender, cytomegalovirus and Epstein-Barr virus (EBV) infection, treatment protocols, allograft rejection, graft vascular disease (GVD), and lymphoma. Immunohistochemistry was performed to determine Quilty cell composition. Quilty incidence was 49.77% in adults and 68.18% in children, and did not appear to be influenced by cyclosporine dosage. Quilty showed no gender variation nor association with cytomegalovirus (CMV) or EBV infection or lymphoma. A total of 74.04% of adults developed Quilty within the first year posttransplant and 81.48% had multiple Quilty-positive biopsies. One hundred eight of 217 Quilty-positive adults had 456 Quilty-positive endomyocardial biopsies, 82.24% of which were associated with an ISHLT grade of 0 or I, and only 12.28% being associated with a grade III rejection. Histological division into Quilty A and Quilty B did not appear to have clinical significance. Graft vascular disease appears to have decreased significantly more in Quilty-positive patients. Although our findings in children were similar to those in the adults, we were unable to draw definite conclusions, the number of children being too small to permit valid statistical correlations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750939     DOI: 10.1016/0046-8177(95)90252-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  B cells in cardiac transplants: from clinical questions to experimental models.

Authors:  William M Baldwin; Marc K Halushka; Anna Valujskikh; Robert L Fairchild
Journal:  Semin Immunol       Date:  2011-09-19       Impact factor: 11.130

2.  Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

Authors:  A C Tsamandas; S M Pham; E C Seaberg; O Pappo; R L Kormos; A Kawai; B P Griffith; A Zeevi; R Duquesnoy; J J Fung; T E Starzl; A J Demetris
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

Review 3.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

4.  Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.

Authors:  A J Demetris; N Murase; Q Ye; F H Galvao; C Richert; R Saad; S Pham; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 5.  [Heart transplantation. Pathology, clinical work-up and therapy].

Authors:  H A Baba; J Wohlschläger; J Stypmann; N E Hiemann
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

6.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05

7.  T cell apoptosis in human heart allografts: association with lack of co-stimulation?

Authors:  E Van Hoffen; D F Van Wichen; J C Leemans; R A Broekhuizen; A H Bruggink; M De Boer; N De Jonge; H Kirkels; P J Slootweg; F H Gmelig-Meyling; R A De Weger
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Diagnostic Pitfalls and Challenges in Interpretation of Heart Transplantation Rejection in Endomyocardial Biopsies With Focus on our Experience.

Authors:  Kambiz Mozaffari; Hooman Bakhshandeh; Ahmad Amin; Nasim Naderi; Sepideh Taghavi; Zahra Ojaghi-Haghighi; Mahsa Abdollahi
Journal:  Res Cardiovasc Med       Date:  2014-02-24

9.  Clinical utilities of peripheral blood gene expression profiling in the management of cardiac transplant patients.

Authors:  Kenneth C Fang
Journal:  J Immunotoxicol       Date:  2007-07       Impact factor: 3.000

10.  Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T-cell killing.

Authors:  Xiang Zheng; Stephan Halle; Kai Yu; Pooja Mishra; Michaela Scherr; Stefan Pietzsch; Stefanie Willenzon; Anika Janssen; Jasmin Boelter; Denise Hilfiker-Kleiner; Matthias Eder; Reinhold Förster
Journal:  Eur J Immunol       Date:  2016-03-31       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.